Copyright Reports & Markets. All rights reserved.

Electrosurgical Devices Global Market – Forecast To 2020

Request for Sample of this report
Buy now

1 EXECUTIVE SUMMARY 26

    2 INTRODUCTION 30

    • 2.1 KEY TAKEAWAYS 30
    • 2.2 REPORT SCOPE 31
    • 2.3 REPORT DESCRIPTION 31
    • 2.4 MARKETS COVERED 32
    • 2.5 STAKEHOLDERS 34
    • 2.6 RESEARCH METHODOLOGY 35
      • 2.6.1 MARKET SIZE ESTIMATION 36
      • 2.6.2 MARKET CRACKDOWN AND DATA TRIANGULATION 39
      • 2.6.3 SECONDARY SOURCES 40
      • 2.6.4 PRIMARY SOURCES 40
      • 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 41
      • 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 42
      • 2.6.7 ASSUMPTIONS 42

    3 MARKET OVERVIEW 44

    • 3.1 INTRODUCTION 44
    • 3.2 MARKET SEGMENTATION 45
    • 3.3 FACTORS INFLUENCING MARKET 47
    • 3.4 MARKET DYNAMICS 48
      • 3.4.1 DRIVERS AND OPPORTUNITIES 48
        • 3.4.1.1 Increased use of minimally invasive surgeries 48
        • 3.4.1.2 Rapid growth in the aging population 49
        • 3.4.1.3 Growing number of cosmetic surgery procedures 49
        • 3.4.1.4 Prevalence of obesity and its related surgeries 50
        • 3.4.1.5 Advancement of technology 50
        • 3.4.1.6 Demand for electrosurgical procedures in the emerging regions 51
      • 3.4.2 RESTRAINTS AND THREATS 52
        • 3.4.2.1 Risk of side effects 52
        • 3.4.2.2 Rising incidence of product recalls 52
        • 3.4.2.3 Preference for non-invasive procedures 53
        • 3.4.2.4 Healthcare reforms especially government pressure to minimize

      healthcare costs 53

      • 3.4.2.5 Pricing pressure on device manufacturers 54
  • 3.5 REGULATORY AFFAIRS 54
    • 3.5.1 THE U.S. 55
    • 3.5.2 EUROPE 56
    • 3.5.3 CHINA 57
    • 3.5.4 INDIA 58
    • 3.5.5 JAPAN 59
  • 3.6 PORTER’S FIVE FORCE ANALYSIS 60
    • 3.6.1 THREAT OF NEW ENTRANTS 61
    • 3.6.2 THREAT OF SUBSTITUTES 62
    • 3.6.3 BARGAINING POWER OF SUPPLIERS 62
    • 3.6.4 BARGAINING POWER OF BUYERS 63
    • 3.6.5 RIVALRY AMONG EXISTING COMPETITORS 63
  • 3.7 MARKET SHARE ANALYSIS 64
  • 3.8 PATENT TRENDS 67
  • 3.9 REIMBURSEMENT SCENARIO 69
  • 3.10 TECHNOLOGIC ADVANCEMENTS 72
  • 3.11 SUPPLY CHAIN ANALYSIS 72

    • 4 ELECTROSURGICAL DEVICES MARKET, BY PRODUCTS 75

    • 4.1 INTRODUCTION 75
    • 4.2 ELECTROSURGICAL GENERATORS AND MONITORS 78
    • 4.3 ELECTROSURGICAL INSTRUMENTS/UNITS 81
      • 4.3.1 MONOPOLAR INSTRUMENTS 85
        • 4.3.1.1 Contact monopolar instruments 88
        • 4.3.1.1.1 Electrosurgical electrodes 92
        • 4.3.1.1.2 Electrosurgical pencils 94
        • 4.3.1.1.3 Suction coagulators and irrigation devices 96
        • 4.3.1.1.4 Monopolar forceps 98
        • 4.3.1.2 Non-contact (plasma)monopolar instruments 100
        • 4.3.1.2.1 Argon based systems 104
        • 4.3.1.2.2 Helium based systems 106
        • 4.3.2 BIPOLAR INSTRUMENTS/UNITS 108
          • 4.3.2.1 Vessel sealing devices 111
          • 4.3.2.2 Bipolar forceps 113
      • 4.4 SMOKE MANAGEMENT SYSTEMS 115
      • 4.5 ELECTROSURGICAL ACCESSORIES 118
        • 4.5.1 PATIENT RETURN ELECTRODES 122
        • 4.5.2 SMOKE MANAGEMENT SYSTEM ACCESSORIES 124
        • 4.5.3 FOOT SWITCHES, CORDS, CABLES AND ADAPTERS 126
        • 4.5.4 OTHER ACCESSORIES (DISPOSABLES, CARE AND CLEANING AGENTS) 127

      5 ELECTROSURGICAL DEVICES MARKET, BY SURGERY 129

      • 5.1 INTRODUCTION 129
      • 5.2 CARDIOVASCULAR SURGERY 132
      • 5.3 COSMETIC & DERMATOLOGY SURGERY 134
      • 5.4 DENTAL SURGERY 137
      • 5.5 GASTROINTESTINAL SURGERY 139
      • 5.6 GENERAL SURGERY 143
      • 5.7 GYNECOLOGICAL SURGERY 145
      • 5.8 NEUROLOGICAL SURGERY 147
      • 5.9 ONCOLOGY 149
      • 5.10 ORTHOPEDIC SURGERY 151
      • 5.11 UROLOGY 153
      • 5.12 OTHERS 155

      6 REGIONAL MARKET ANALYSIS 157

      • 6.1 INTRODUCTION 157
      • 6.2 NORTH AMERICA 160
        • 6.2.1 UNITED STATES (U.S.) 179
        • 6.2.2 REST OF NORTH AMERICA 184
      • 6.3 EUROPE 188
        • 6.3.1 GERMANY 204
        • 6.3.2 FRANCE 209
        • 6.3.3 UNITED KINGDOM (U.K.) 213
        • 6.3.4 REST OF EUROPE 217
      • 6.4 ASIA PACIFIC 221
        • 6.4.1 JAPAN 240
        • 6.4.2 CHINA 244
        • 6.4.3 INDIA 248
        • 6.4.4 REST OF APAC 253
      • 6.5 REST OF THE WORLD (ROW) 257
        • 6.5.1 BRAZIL 276
        • 6.5.2 REST OF LATIN AMERICA (LATAM) 280
        • 6.5.3 MIDDLE EAST & AFRICA 284

      7 COMPANY DEVELOPMENTS 288

      • 7.1 INTRODUCTION 288
      • 7.2 NEW PRODUCT LAUNCHES 289
      • 7.3 ACQUISITIONS 291
      • 7.4 OTHERS (AGREEMENTS & APPROVALS) 292

      8 MAJOR COMPANIES 293

      • 8.1 APPLIED MEDICAL RESOURCE CORPORATION 293
        • 8.1.1 OVERVIEW 293
        • 8.1.2 FINANCIALS 293
        • 8.1.3 PRODUCT PORTFOLIO 294
        • 8.1.4 KEY DEVELOPMENTS 294
        • 8.1.5 BUSINESS STRATEGY 294
        • 8.1.6 SWOT ANALYSIS 295
      • 8.2 B. BRAUN MELSUNGEN AG 296
        • 8.2.1 OVERVIEW 296
        • 8.2.2 FINANCIALS 297
        • 8.2.3 PRODUCT PORTFOLIO 299
        • 8.2.4 KEY DEVELOPMENTS 300
        • 8.2.5 BUSINESS STRATEGY 300
        • 8.2.6 SWOT ANALYSIS 301
      • 8.3 BOWA-ELECTRONIC GMBH & CO.KG 302
        • 8.3.1 OVERVIEW 302
        • 8.3.2 FINANCIALS 302
        • 8.3.3 PRODUCT PORTFOLIO 303
        • 8.3.4 KEY DEVELOPMENTS 304
        • 8.3.5 BUSINESS STRATEGY 304
        • 8.3.6 SWOT ANALYSIS 305
      • 8.4 CONMED CORPORATION 306
        • 8.4.1 OVERVIEW 306
        • 8.4.2 FINANCIALS 307
        • 8.4.3 PRODUCT PORTFOLIO 309
        • 8.4.4 KEY DEVELOPMENTS 311
        • 8.4.5 BUSINESS STRATEGY 311
        • 8.4.6 SWOT ANALYSIS 312
      • 8.5 ERBE ELEKTROMEDIZIN GMBH 313
        • 8.5.1 OVERVIEW 313
        • 8.5.2 FINANCIALS 313
        • 8.5.3 PRODUCT PORTFOLIO 314
        • 8.5.4 KEY DEVELOPMENTS 315
        • 8.5.5 BUSINESS STRATEGY 316
        • 8.5.6 SWOT ANALYSIS 317
      • 8.6 JOHNSON & JOHNSON (ETHICON & MEGADYNE) 318
        • 8.6.1 OVERVIEW 318
        • 8.6.2 FINANCIALS 319
        • 8.6.3 PRODUCT PORTFOLIO 323
        • 8.6.4 KEY DEVELOPMENTS 324
        • 8.6.5 BUSINESS STRATEGY 325
        • 8.6.6 SWOT ANALYSIS 326
      • 8.7 KLS MARTIN GROUP 327
        • 8.7.1 OVERVIEW 327
        • 8.7.2 FINANCIALS 327
        • 8.7.3 PRODUCT PORTFOLIO 328
        • 8.7.4 KEY DEVELOPMENTS 329
        • 8.7.5 BUSINESS STRATEGY 329
        • 8.7.6 SWOT ANALYSIS 330
      • 8.8 MEDTRONIC, PLC 331
        • 8.8.1 OVERVIEW 331
        • 8.8.2 FINANCIALS 332
        • 8.8.3 PRODUCT PORTFOLIO 336
        • 8.8.4 KEY DEVELOPMENTS 337
        • 8.8.5 BUSINESS STRATEGY 338
        • 8.8.6 SWOT ANALYSIS 339
      • 8.9 OLYMPUS CORPORATION 340
        • 8.9.1 OVERVIEW 340
        • 8.9.2 FINANCIALS 341
        • 8.9.3 PRODUCT PORTFOLIO 344
        • 8.9.4 KEY DEVELOPMENTS 344
        • 8.9.5 BUSINESS STRATEGY 345
        • 8.9.6 SWOT ANALYSIS 346
      • 8.10 SMITH & NEPHEW PLC 347
        • 8.10.1 OVERVIEW 347
        • 8.10.2 FINANCIALS 348
        • 8.10.3 PRODUCT PORTFOLIO 350
        • 8.10.4 KEY DEVELOPMENTS 352
        • 8.10.5 BUSINESS STRATEGY 352

    Electrosurgery uses electrical energy to create thermal destruction of tissue through coagulation. Electrosurgical devices are the medical devices used for almost all types of surgeries such as cardiac, orthopedic, cosmetic and dermatological, gynecological, plastic surgery, ENT, maxillofacial, urological, neurological and general surgical procedures as well as certain dental procedures, etc. Electrosurgical units (ESU’s) are used for surgical cutting or to manage blood loss by causing coagulation (homoeostasis) during surgery. Worldwide people are opting for the electrosurgical devices based surgeries. The increasing acceptance of electrosurgical devices is mainly due to the advancements in electrosurgical devices such as reduction of collateral damage to tissues, eschar (dead tissues) formation and also limiting the sticking of tissues. According to IQ4I analysis, the electrosurgical devices global market is expected to grow at a mid single digit CAGR to reach $6,273.2 million by 2025.
    The market for electrosurgical devices is segmented mainly based on products, surgery and geography. Electrosurgical devices product market is segmented as electrosurgical electrodes, instruments/units, smoke management, and accessories. Instruments/units market held the largest share. Electrosurgical instruments/units are further sub-segmented as monopolar and bipolar instruments, where monopolar instruments occupied the largest share during 2018. Bipolar instruments are projected to grow at a mid-single digit CAGR from 2018 to 2025. The monopolar instruments market is further segmented into contact and non-contact monopolar instruments. Among the contact monopolar instruments electrosurgical pencils commanded the largest revenue in 2018, in the non-contact instruments market Argon conductive gas based segment commanded the largest revenue during 2018. The Helium based segment is expected to grow at a high single digit CAGR from 2018 to 2025.
    According to IQ4I analysis, in surgery market, oncology commanded the largest revenue of in 2018 and is expected to grow at mid-single digit CAGR from 2018 to 2025. As more and more cancer patients opt for minimally invasive surgeries for treatment, the market is experiencing growth. With a desire to appear more youthful and increasing significance of external appearance more people are undergoing cosmetic surgery driving the cosmetic and dermatological surgery market which is expected to be fastest growing market.
    Based on geography the market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others) and Rest of the World (Brazil, Middle East & others and Rest of Latin America). North-America commanded the largest revenue of in 2018 during 2018 due to advancements in technology, adoption of electrosurgical instruments in all types of surgeries, minimally- invasive surgeries, healthcare expenditures by government reforms, and an aging population and availability of skilled labors. Asia-Pacific is expected to grow a fastest rate due to growing awareness of the people and increasing demand for safe, cost effective minimally-invasive procedures.
    Major players in this market are Apyx Medical (U.S.), B.Braun Melsungen AG (Germany), Bowa medical (Germany), Conmed (U.S.), ERBE Electronics (Germany), J&J (Ethicon & Megadyne) (U.S.), Medtronic (Ireland), Olympus (Japan), Smith & Nephew (U.K.), Utah Medical (U.S.), Applied Medical (U.S.), and KLS Martin (Germany).
    Buy now